candesartan cilexetil has been researched along with atrial natriuretic factor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akioka, K; Hanatani, A; Iwao, H; Kim, S; Omura, T; Takeda, T; Takeuchi, K; Teragaki, M; Toda, I; Yoshiyama, M | 1 |
| Fukai, D; Kinoshita, M; Maeda, Y; Tsutamoto, T; Wada, A | 1 |
| Knoshita, M; Wada, A | 1 |
| Kinoshita, M; Wada, A | 1 |
| Hanatani, A; Iwao, H; Kim, S; Nakayama, K; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
| Fujii, M; Hayashi, M; Kinoshita, M; Mabuchi, N; Maeda, K; Matsumoto, T; Ohnishi, M; Sawaki, M; Tsutamoto, T; Tsutsui, T; Wada, A | 1 |
| Yasue, H; Yoshimura, M | 1 |
| Alegria, E; Arens, HA; Dabrowski, M; Dukát, A; Kiowski, W; Lenz, K; Marks, DS; Miric, M; Mitrovic, V; Seferovic, P; Spinar, J; Willenbrock, R | 1 |
| Akioka, K; Iwao, H; Izumi, Y; Kim, S; Matsumoto, R; Nakamura, Y; Omura, T; Takeuchi, K; Yoshikawa, J; Yoshiyama, M | 1 |
1 review(s) available for candesartan cilexetil and atrial natriuretic factor
| Article | Year |
|---|---|
[Disorders of body water regulation and the therapy--role of atrial natriuretic peptide in homeostasis of body water in heart failure].
Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Azepines; Benzimidazoles; Biphenyl Compounds; Body Water; Down-Regulation; Endothelin Receptor Antagonists; Heart Failure; Homeostasis; Humans; Indoles; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Atrial Natriuretic Factor; Sodium; Tetrazoles | 1997 |
2 trial(s) available for candesartan cilexetil and atrial natriuretic factor
| Article | Year |
|---|---|
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cell Adhesion Molecules; Cyclic GMP; Female; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Natriuretic Peptide, Brain; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2000 |
Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Hormones; Humans; Male; Middle Aged; Placebos; Prodrugs; Regression Analysis; Renin; Tetrazoles; Treatment Outcome | 2003 |
6 other study(ies) available for candesartan cilexetil and atrial natriuretic factor
| Article | Year |
|---|---|
Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Base Sequence; Benzimidazoles; Biphenyl Compounds; DNA, Complementary; Gene Expression; Male; Molecular Sequence Data; Myocardial Infarction; Myosin Heavy Chains; Rats; Rats, Wistar; Tetrazoles; Transforming Growth Factor beta | 1995 |
Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Dogs; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Kidney; Male; Norepinephrine; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Time Factors; Vascular Resistance | 1997 |
A functional role for endogenous atrial natriuretic peptide in the maintenance of body fluid balance in heart failure.
Topics: Angiotensin Receptor Antagonists; Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Cyclic GMP; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Endothelins; Heart Failure; Polysaccharides; Receptors, Atrial Natriuretic Factor; Renin-Angiotensin System; Tetrazoles; Water-Electrolyte Balance | 1998 |
Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Calcium-Transporting ATPases; Collagen; Contractile Proteins; Echocardiography; Gene Expression; Heart Ventricles; Hemodynamics; Male; Myocardial Infarction; Organ Size; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; RNA, Messenger; Sodium-Calcium Exchanger; Tetrazoles; Ventricular Dysfunction, Left | 1998 |
Hemodynamic and hormonal effects of the angiotensin II antagonist, candesartan cilexetil, in patients with congestive heart failure.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biomarkers; Biphenyl Compounds; Cardiac Catheterization; Echocardiography; Heart Failure; Hemodynamics; Hormones; Humans; Natriuretic Peptide, Brain; Pulmonary Wedge Pressure; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Retrospective Studies; Stroke Volume; Tetrazoles; Vascular Resistance | 2000 |
Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction.
Topics: Animals; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Collagen Type I; Collagen Type III; Drug Synergism; Echocardiography; Gene Expression Profiling; Heart; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; NF-kappa B; Rats; Rats, Wistar; Receptors, Angiotensin; Receptors, Mineralocorticoid; RNA, Messenger; Spironolactone; Tetrazoles; Transcription Factor AP-1; Ventricular Function, Left; Ventricular Remodeling | 2004 |